Hepatic encephalopathy. Clinical case
DOI:
https://doi.org/10.12775/JEHS.2021.11.05.017Keywords
hepatic encephalopathy, West Haven classification, liver cirrhosis, pathogenesis, neurotransmitters, ammonia, asterixis, clinical caseAbstract
Hepatic encephalopathy is a neuropsychiatric syndrome associated with abnormal liver function and portosystemic venous shunting. According to the West-Haven classification, depending on the degree of neurological disorders, there are minimal, I - IV stages of HE, which are characterized by a gradual progression of the disease. To date, the pathogenesis of HE is controversial.References
Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases // J Hepatol 2014;61:642–659.
Montagnese S, Russo FP, Amodio P, Burra P, Gasbarrini A, Loguercio C. Hepatic encephalopathy 2018 A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) Dig Liver Dis. 2019;51:190–205. et al. [https://doi.org/10.1016/j.dld.2018.11.035
Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. // Hepatology. 2002 Mar. 35(3):716-21.
Kappus MR, Bajaj JS. Covert hepatic encephalopathy: not as minimal as you might think. ClinGastroenterolHepatol. 2012 Nov. 10(11):1208-19.
Chatauret N, Butterworth RF. Effects of liver failure on inter-organ trafficking of ammonia: implications for the treatment of hepatic encephalopathy. J GastroenterolHepatol. 2004. 19:S219-223.
Brusilow SW. Hyperammonemic encephalopathy. Medicine (Baltimore). 2002 May. 81(3):240-9.
Ahboucha S, Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint. Metab Brain Dis. 2004 Dec. 19(3-4):331-43.
Lorenzo Ridola, Jessica Faccioli, Silvia Nardelli, StefaniaGioia, OlivieroRiggioHepatic Encephalopathy: Diagnosis and Management J TranslInt Med . 2020 Dec 31;8(4):210-219.doi: 10.2478/jtim-2020-0034.
Ridola L, Cardinale V, Riggio O. The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies. Ann Gastroenterol. 2018;31:151–64.
Ridola L, Nardelli S, Gioia S, Riggio O. Quality of life in patients with minimal hepatic encephalopathy. World J Gastroenterol. 2018;24:5446–53.
Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol. 2000;95:2029–34. et al.
Nathan M Bass, Kevin D Mullen, ArunSanyal, Fred Poordad, Guy Neff, Carroll B Leevy, Samuel Sigal, Muhammad Y Sheikh, Kimberly Beavers, Todd Frederick, Lewis Teperman, Donald Hillebrand, Shirley Huang, Kunal Merchant, Audrey Shaw, Enoch Bortey, William P ForbesRifaximin treatment in hepatic encephalopathy N Engl J Med 2010 Vol. 362(12). P.1071-81.doi: 10.1056/NEJMoa0907893.
Poujois A, Woimant F. Wilson's disease: A 2017 update Clin Res HepatolGastroenterol. 2018 Dec;42(6):512-520. doi: 10.1016/j.clinre.2018.03.007
Chiara Saroli Palumbo, Michael L. Schilsky Clinical practice guidelines in Wilson disease Ann Transl Med. 2019 Apr; 7(Suppl 2): S65. doi:10.21037/atm.2018.12.53
Roberts EA, Schilsky ML, American Association for Study of Liver Diseases (AASLD) Diagnosis and treatment of Wilson disease: an update. Hepatology2008;47:2089-111.
European Association for Study of Liver EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol2012;56:671-85. 10.1016/j.jhep.2011.11.007
Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A. members of the ISHEN commission on Neurophysiological Investigations. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines Liver Int. 2009;29:789–96. et al.
CDC. Reye Syndrome 1990 Clinical Case Definition. Available at http://www.cdc.gov/ncphi/disss/nndss/casedef/reye_syndrome_current.htm.
Clauson KA, Santamarina ML, Buettner CM, Cauffield JS. Evaluation of presence of aspirin-related warnings with willow bark. Ann Pharmacother. 2005 Jul-Aug;39(7-8):1234-7.
Mitchell RA, Arcinue EL, Partin JC, Partin JS, Ram ML, Chang CH, Smialek J, Sarnaik A. Quantitative evaluation of the extent of hepatic enzyme changes in Reye syndrome compared with normal liver or with non-Reye liver disorders: objective criteria for animal models. Pediatr Res. 1985 Jan;19(1):19-22.
Lovejoy FH Jr, Smith AL, Bresnan MJ, Wood JN, Victor DI, Adams PC. Clinical staging in Reye syndrome. Am J Dis Child. 1974 Jul. 128(1):36-41.
Wang Y.F., Kong X., Lu G.M., Zhang L.J. Diabetes Mellitus is Associated with More Severe Brain Spontaneous Activity Impairment and Gray Matter Loss in Patients with Cirrhosis. Sci. Rep. 2017;7:7775. doi: 10.1038/s41598-017-08075-x.
Garcia-Compean D., Jaquez-Quintana J.O., Gonzalez-Gonzalez J.A., Maldonado-Garza H. Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management. World J. Gastroenterol. 2009;15:280–288. doi: 10.3748/wjg.15.280.
Elkrief L., Rautou P.E., Sarin S., Valla D., Paradis V., Moreau R. Diabetes mellitus in patients with cirrhosis: Clinical implications and management. Liver Int. 2016;36:936–948. doi: 10.1111/liv.13115.
De Silva N.M.G., Borges M.C., Hingorani A.D., Engmann J., Shah T., Zhang X., Luan J., Langenberg C., Wong A., Kuh D., et al. Liver Function and Risk of Type 2 Diabetes: Bidirectional Mendelian Randomization Study. Diabetes. 2019;68:1681–1691. doi: 10.2337/db18-1048.
Sookoian S., Castano G.O., Scian R., Fernandez Gianotti T., Dopazo H., Rohr C., Gaj G., San Martino J., Sevic I., Flichman D., et al. Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level. Am. J. Clin. Nutr. 2016;103:422–434. doi: 10.3945/ajcn.115.118695.
Jepsen P., Watson H., Andersen P.K., Vilstrup H. Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients. J. Hepatol. 2015;63:1133–1138. doi: 10.1016/j.jhep.2015.07.007.
Galvin R, Bråthen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy.Eur J Neurol. 2010;17(12):1408-18. doi:10.1111/j.1468-1331.2010.03153.x
Kopelman MD, Thomson AD, Guerrini I, Marshall EJ. The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol Alcohol. 2009;44(2):148-54. doi:10.1093/alcalc/agn118
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 877
Number of citations: 0
